481 related articles for article (PubMed ID: 27533057)
1. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
4. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
[TBL] [Abstract][Full Text] [Related]
6. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
Yang SC; Wu CK; Tai WC; Liang CM; Yao CC; Wu KL; Hsu CN; Chuah SK
J Gastroenterol Hepatol; 2021 Jul; 36(7):1828-1835. PubMed ID: 33247982
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
8. Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.
He W; Shu X; Zhu E; Deng B; Lin Y; Wu X; Zhou Z; Wang J; Nie R
BMC Cardiovasc Disord; 2021 Feb; 21(1):75. PubMed ID: 33546595
[TBL] [Abstract][Full Text] [Related]
9. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
Bhurke SM; Martin BC; Li C; Franks AM; Bursac Z; Said Q
Pharmacotherapy; 2012 Sep; 32(9):809-18. PubMed ID: 22744772
[TBL] [Abstract][Full Text] [Related]
10. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
11. Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.
Zou JJ; Chen SL; Tan J; Lin L; Zhao YY; Xu HM; Lin S; Zhang J; Fan HW; Xie HG
PLoS One; 2014; 9(1):e84985. PubMed ID: 24416326
[TBL] [Abstract][Full Text] [Related]
12. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
[TBL] [Abstract][Full Text] [Related]
14. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
[TBL] [Abstract][Full Text] [Related]
15. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327
[TBL] [Abstract][Full Text] [Related]
16. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
[TBL] [Abstract][Full Text] [Related]
17. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.
Charlot M; Grove EL; Hansen PR; Olesen JB; Ahlehoff O; Selmer C; Lindhardsen J; Madsen JK; Køber L; Torp-Pedersen C; Gislason GH
BMJ; 2011 May; 342():d2690. PubMed ID: 21562004
[TBL] [Abstract][Full Text] [Related]
19. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
[TBL] [Abstract][Full Text] [Related]
20. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
